Trial aims to slash dangerous steroid side effects in serious autoimmune disease

NCT ID NCT06983821

Recruiting now Disease control Sponsor: Ottawa Hospital Research Institute Source: ClinicalTrials.gov ↗

Summary

This study is testing a new treatment plan for a serious autoimmune disease that attacks the kidneys (ANCA-associated vasculitis). It compares a much shorter, 4-week course of steroids (glucocorticoids) combined with standard drugs to the current standard treatment, which uses steroids for over 6 months. The goal is to see if the shorter steroid plan can control the disease just as well while causing far fewer serious side effects, especially dangerous infections.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRANULOMATOSIS WITH POLYANGIITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

St-Joseph's Hospital
NOT_YET_RECRUITING

Hamilton, Ontario, Canada
The Ottawa Hospital
RECRUITING

Ottawa, Ontario, Canada

Conditions

Explore the condition pages connected to this study.

GRANULOMATOSIS WITH POLYANGIITIS MICROSCOPIC POLYANGIITIS (MPA)